Company intelligence / Profile preview

Ziosoft

Tokyo, Japan

Ownership: Private
Development stage: Other

Overview

Ziosoft provides advanced visualization and analysis software for medical imaging with thousands of systems installed in more than 30 countries. The company's flagship platform, Ziostation REVORAS, enables automated segmentation and surgical planning for complex procedures like lung segmentectomy. Notable capabilities include CT colonography (virtual colonoscopy), CT lung analysis with automatic segmentation of anatomical structures, and cardiac function analysis.

Therapeutic areas: OncologyCardiovascularNeurologyGastroenterology
Modalities: Non-pharmacological therapy (software-based visualization and analysis)
Industry: Medical Imaging

Partnerships

Collaborations with academic medical institutes in Japan for clinical application developmentpartnerships with regional distributors including iMedIT in Turkey

Beyond the preview

Go deeper on Ziosoft.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ziosoft.

Explore the full profile